These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 20519123)

  • 21. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
    Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
    Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1.
    Subramaniam N; Campión J; Rafter I; Okret S
    Biochem J; 2003 Mar; 370(Pt 3):1087-95. PubMed ID: 12487626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
    Hildebrandt S; Baschant U; Thiele S; Tuckermann J; Hofbauer LC; Rauner M
    Sci Rep; 2018 Jun; 8(1):8711. PubMed ID: 29880826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid receptor antagonizes EGFR function to regulate eyelid development.
    Sanchis A; Bayo P; Sevilla LM; Pérez P
    Int J Dev Biol; 2010; 54(10):1473-80. PubMed ID: 21136383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
    Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
    J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization.
    Eijken M; Koedam M; van Driel M; Buurman CJ; Pols HA; van Leeuwen JP
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):87-93. PubMed ID: 16406260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
    Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
    J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.
    Costas M; Trapp T; Pereda MP; Sauer J; Rupprecht R; Nahmod VE; Reul JM; Holsboer F; Arzt E
    J Clin Invest; 1996 Sep; 98(6):1409-16. PubMed ID: 8823306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
    Kleiman A; Tuckermann JP
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glucocorticoid receptor gene as a candidate for gene therapy in asthma.
    Mathieu M; Gougat C; Jaffuel D; Danielsen M; Godard P; Bousquet J; Demoly P
    Gene Ther; 1999 Feb; 6(2):245-52. PubMed ID: 10435109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
    Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation.
    Ishida Y; Heersche JN
    J Bone Miner Res; 1998 Dec; 13(12):1822-6. PubMed ID: 9844099
    [No Abstract]   [Full Text] [Related]  

  • 34. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor.
    Reichardt HM; Tuckermann JP; Göttlicher M; Vujic M; Weih F; Angel P; Herrlich P; Schütz G
    EMBO J; 2001 Dec; 20(24):7168-73. PubMed ID: 11742993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
    Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
    Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
    Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
    Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
    Kim J; Xing W; Wergedal J; Chan JY; Mohan S
    Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of glucocorticoid action in bone cells.
    Delany AM; Dong Y; Canalis E
    J Cell Biochem; 1994 Nov; 56(3):295-302. PubMed ID: 7876321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.